A new drug being tested for colorectal cancer has left doctors stunned after it returned a 100 percent success rate in clinical trials.
Dostarlimab, a drug with laboratory-produced molecules that act as a substitute antibodies in the human body, left researches astonished after all 18 participants were considered in remission one year after the drug trial.
Doctors conducted physical exams, endoscopies, PET scans and MRI scans and were unable to find any trace of cancer in their bodies.
Dr Luis A, Diaz Jr. of New York’s Memorial Sloan Kettering Cancer Center said ‘this was the first time this has happened in the history of cancer’.
This is definitely a game changer!